BIND Therapeutics Recognized by the World Economic Forum as a Technology Pioneer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Therapeutics, a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that it has been recognized by the World Economic Forum as a Technology Pioneer 2014. The Technology Pioneers 2014 will be honored at the Forum’s Annual Meeting of the New Champions 2013 in Dalian, People’s Republic of China, from 11 to 13 September.

Help employers find you! Check out all the jobs and post your resume.